Corrigendum to “fecal Clostridium Symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies” [ebiomedicine 25 (2017) 32–40]

Yuan-Hong Xie,Qin-Yan Gao,Guo-Xiang Cai,Xiao-Min Sun,Tian-Hui Zou,Hui-Min Chen,Si-Yi Yu,Yi-Wen Qiu,Wei-Qi Gu,Xiao-Yu Chen,Yun Cui,Danfeng Sun,Zhan-Ju Liu,San-Jun Cai,Jie Xu,Ying-Xuan Chen,Jing-Yuan Fang
DOI: https://doi.org/10.1016/j.ebiom.2018.02.014
IF: 11.205
2018-01-01
EBioMedicine
Abstract:The authors regret that the name of the 4th author (Xiao-Ming Sun) was misspelled. The correct name should be Xiao-Min Sun. Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation StudiesCurrent non-invasive early detection of colorectal cancer (CRC) requires improvement. We aimed to identified a fecal Clostridium symbiosum-based biomarker for early and advanced colorectal cancer detection. Full-Text PDF Open Access
What problem does this paper attempt to address?